SkinMicrobiome SIGNED
Paradigm Change in Skin Health: Novel Microbiome-based Cosmetics for Acne and Other Skin Conditions
Total Cost €
0EC-Contrib. €
0Partnership
0Views
0SkinMicrobiome project word cloud
Explore the words cloud of the SkinMicrobiome project. It provides you a very rough idea of what is the project "SkinMicrobiome" about.
Project "SkinMicrobiome" data sheet
The following table provides information about the project.
| Coordinator |
S-BIOMEDIC
Organization address contact info |
| Coordinator Country | Belgium [BE] |
| Total cost | 1˙856˙055 € |
| EC max contribution | 1˙299˙238 € (70%) |
| Programme |
1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs) 3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies) |
| Code Call | H2020-EIC-SMEInst-2018-2020-3 |
| Funding Scheme | SME-2b |
| Starting year | 2020 |
| Duration (year-month-day) | from 2020-02-01 to 2022-01-31 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | S-BIOMEDIC | BE (BEERSE) | coordinator | 1˙299˙238.00 |
Map
Project objective
S-Biomedic has developed a disruptive technology to directly modulate the skin microbiome, enabling a wide range of applications in dermatology. The first product is a cosmetic for acne prone skin (TRL6) with proven efficacy and safety in an area where competing products are either ineffective or cause severe side-effects.
Acne is amongst the 10 most prevalent diseases globally and the main reason for people to consult a dermatologist. It affects the life quality of millions of Europeans and represents a market of €4.4 billion. S-Biomedic’s novel skin probiotic product will be launched in 2021 in selected European countries, and will allow reducing current treatments from years to weeks and preventing the actual relapse episodes of acne.
S-Biomedic is leading the skin microbiome field based on a unique combination of approach, technology and careful IPR protection. Backed by global industrial partners with an unparalleled reputation in the personal care industries, such as Johnson & Johnson, DSM and Beiersdorf, S-Biomedic has successfully accelerated its R&D and turned its platform technology into a high-potential product pipeline. However, the ambitious challenge posed by the launch of a new cosmetic product in the market can only be met to its full potential with the support of the EIC pilot.
The SkinMicrobiome project will support S-Biomedic in the route to market and accelerate its growth, enabling sales >€55M by 2028, positioning it among the Top 10 acne brands globally, with a projected market share of 2,58%. SkinMicrobiome will allow to hire employees with commercial and marketing background, who will complement a multidisciplinary team led by excellent business and scientific professionals. SkinMicrobiome will become a key cornerstone for the successful launch of the first highly innovative cosmetic and will enable S-Biomedic to lead at the forefront of microbiome-based solutions not only in Europe but also on a global level.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SKINMICROBIOME" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "SKINMICROBIOME" are provided by the European Opendata Portal: CORDIS opendata.
More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)
Osto.Me (2020)
Ostomy Market Disruption: First Leak Proof Ostomy Appliance removing the need for Accessories in the Ostomy Market
Read More